CD Diagnostics is a fully integrated diagnostics company with expertise in immunoassay development and commercialization. Our company combines expertise in immunoassay expertise with biomarker research, patented technology, and GMP manufacturing to deliver a range of products that address challenging diagnostic issues. We are improving patient outcomes by providing more accurate and rapid diagnosis. CD Diagnostics recently completed the acquisition of Citrano Medical Laboratories, a CLIA-certified laboratory that has provided comprehensive clinical testing services to clients for 39 years. Our CLIA laboratory and sample acquisition programs with major hospitals and medical research institutions facilitate the rapid development and commercialization of laboratory developed tests.
Our laboratory developed tests and point of care products are used to diagnose a broad range of diseases, track the progression of disease, and measure the effectiveness of therapeutic treatments. Our competitive advantage lies in our ability to develop customized programs with great flexibility, adhere to client timelines, and provide a personalized level of service that is unmatched by competitors. We offer biomarker screening services, assay development, CLIA-certified clinical laboratory testing, and product commercialization services. These capabilities, coupled with our sample acquisition network, patented technology, and strong management team make CD Diagnostics the perfect partner for assay development projects. Our first laboratory developed test for periprosthetic joint infection, developed with Zimmer, was released in November 2012. We are developing additional tests for other disease states and use as companion diagnostics.